Accounts Receivable, after Allowance for Credit Loss, Current of LakeShore Biopharma Co., Ltd. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
LakeShore Biopharma Co., Ltd. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Mar 2025 was $69,783,067, a 11% increase year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in CNY history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Mar 2025 was ¥500,916,815, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (CNY)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $69,783,067 +$7,181,053 +11% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 $62,602,014 -$4,783,319 -7.1% 31 Mar 2024 20-F 15 Aug 2024 2024 FY
Q1 2023 $67,385,333 31 Mar 2023 20-F 26 Jul 2023 2023 FY

LakeShore Biopharma Co., Ltd. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥500,916,815 +¥56,755,524 +13% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 ¥444,161,291 -¥18,890,501 -4.1% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q1 2023 ¥463,051,792 +¥154,496,687 +50% 31 Mar 2023 20-F 15 Aug 2024 2024 FY
Q1 2022 ¥308,555,105 31 Mar 2022 20-F 26 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.